MEDICUS SCIENCES ACQUISITION - *W EXP 02/12/202 (MSACW)

CUSIP: G5960S124

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / *W EXP 02/12/202
Total 13F shares
711,059
Share change
+711,059
Total reported value
$719,000
Price per share
$1.01
Number of holders
16
Value change
+$719,000
Number of buys
16

Quarterly Holders Quick Answers

What is CUSIP G5960S124?
CUSIP G5960S124 identifies MSACW - MEDICUS SCIENCES ACQUISITION - *W EXP 02/12/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MEDICUS SCIENCES ACQUISITION - *W EXP 02/12/202 (MSACW) as of Q2 2021

As of 30 Jun 2021, MEDICUS SCIENCES ACQUISITION - *W EXP 02/12/202 (MSACW) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 711,059 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., Third Point LLC, HealthCor Management, L.P., Tamarack Advisers, LP, Avidity Partners Management LP, GLAZER CAPITAL, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, Kepos Capital LP, Affinity Asset Advisors, LLC, and KINGDON CAPITAL MANAGEMENT, L.L.C.. This page lists 16 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.